A blood test which looks for multiple types of cancer has failed to achieve its key objective in a major NHS trial, the company has announced. The Galleri blood test is being trialled on 142,000 NHS ...

Abstract: Digital scan-based automatic test pattern generation (ATPG) was recently described for ‘random analog’ circuits with >95% likelihood-weighted coverage of the shorts and opens prescribed by ...

Just how small can a QR code be? Small enough that it can only be recognized with an electron microscope. A research team at TU Wien, working together with the data storage technology company Cerabyte ...

Abstract: Harmful content embedded in program elements within source code may have detrimental impact on mental health of software developers, and promote harmful behavior. Our key insight is that ...

Personalis shares rose after the company received Medicare coverage for its NeXT Personal molecular residual disease test for surveillance of patients with Stage I to III non-small cell lung cancer.

Personalis, Inc. PSNL stock is up in Tuesday’s premarket session after the company received Medicare coverage for its NeXT Personal molecular residual disease test for lung cancer surveillance. This ...